- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02887924
SLI MANEUVER and RESPIRATORY MORBIDITIES
THE EFFECT OF SUSTAINED LUNG INFLATION MANEUVER APPLIED THROUGH NASAL PRONG ON EARLY AND LATE RESPIRATORY MORBIDITIES IN PRETERM INFANTS
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary Outcome Measures:
Surfactant need, intubation and mechanical ventilation needs within the first 72 hours of life in SLI (Sustained Lung Inflation) maneuver-applied preterm infants and non-SLI-applied preterm infants.
Secondary Outcome Measures:
- Heart rate, fractional inspiratory oxygen, CPAP pressure and oxygen saturation within the first 72 hours of life in preterm infants
- Total non-invasive, invasive respiratory support time
- The presence of and the degree of BPD (Bronchopulmonary dysplasia)
- Premature morbidities such as PDA (patent ductus arteriosus), IVH (intraventricular hemorrhage), NEC (necrotizing enterocolitis), ROP (retinopathy of prematurity)
- Feeding intolerance, reaching birth weight and transition to full oral feeding time
Study Design Randomization Group 1: Group that received SLI maneuver immediately after birth followed by nCPAP.
Group 2: Group that received nCPAP after birth. Following the oral and nasal aspirates, SLI at 25 cm H2O pressure will be applied for 15 seconds by using t-piece refreshing and binasal prongs and 5-cm nCPAP at H2O pressure will be applied.
Patients will be observed for 5-10 seconds in terms of cardiorespiratory functions following SLI maneuver. If respiratory failure continues during nCPAP (such as apnea, gasping) and/or heart rate is > 60 / min but < 100 / min , SLI maneuver will be repeated at the same pressure for the same time period. If heart rate > 60 / min but <100 / min persists after the second SLI maneuver, resuscitation will be applied in line with the guidelines of American Academy of Pediatrics.
The control group of infants will receive nCPAP support at 5 cm H2O pressure and be supported in line with the guidelines of American Academy of Pediatrics.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Preterm infant with gestational age of 26 weeks 0 days and 29 weeks 6 days will be included.
Exclusion Criteria:
- Presence of major congenital anomaly,
- Patients with hydrops fetalis and pulmonary hypoplasia
- Consent not provided or refused
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: group 1
SLI group In this group the preterm infants will receive sustained lung inflation (SLI) via short binasal prongs in the delivery room.
|
Following the oral and nasal aspirates, SLI at 25 cm H2O pressure will be applied for 15 seconds by using t-piece refreshing and binasal prongs and 5-cm nCPAP at H2O pressure will be applied.
Other Names:
|
Placebo Comparator: group 2
Preterm infants will be assisted in the delivery room without sustained lung inflation.
|
Following the oral and nasal aspirates, SLI at 25 cm H2O pressure will be applied for 15 seconds by using t-piece refreshing and binasal prongs and 5-cm nCPAP at H2O pressure will be applied.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
mechanical ventilation requirement
Time Frame: 72 hours
|
Surfactant requirement, intubation and mechanical ventilation needs within the first 72 hours of life in SLI (Sustained Lung Inflation) maneuver-applied preterm infants and non-SLI-applied preterm infants.
|
72 hours
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12082016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Distress Syndrome
-
Tanta UniversityRecruitingAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Respiratory Distress Syndrome, PediatricEgypt
-
University Hospital, Clermont-FerrandWithdrawn
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Dr Anna Lavizzari; Dr Francesca Gaia CiuffiniCompletedNewborn Respiratory Distress SyndromeItaly
-
Assiut UniversityRecruitingNeonatal Respiratory DistressEgypt
-
Groupe Hospitalier Paris Saint JosephCompletedEarly Neonatal Respiratory Distress: Changes in Level IIb Hospital Over a Period of One Year (DROPE)Neonatal Respiratory Distress SyndromeFrance
-
Karolinska University HospitalCompletedRespiratory Distress Syndrome, Adult | Respiratory Distress Syndrome, ChildSweden
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAcute Respiratory Distress Syndrome ARDS
-
Michael A. MatthayThe University of Texas Health Science Center, Houston; United States Department... and other collaboratorsCompletedRespiratory Distress Syndrome, AdultUnited States
-
Faron Pharmaceuticals LtdSeventh Framework ProgrammeTerminatedRespiratory Distress Syndrome, AdultSpain, United Kingdom, France, Italy, Finland, Czechia, Belgium, Germany
-
Postgraduate Institute of Medical Education and...TerminatedAcute Respiratory Distress Syndrome (ARDS)India
Clinical Trials on Neopuff; Fisher and Paykel, Auckland, New Zealand
-
Hospital Virgen de la SaludCompletedTracheostomy | Airway Management | Respiratory TherapySpain
-
Li XuyanCompletedLung Diseases, ObstructiveChina
-
Concord Repatriation General HospitalCompletedPeritoneal Inflammation | Peritoneum; InjuryAustralia
-
Asan Medical CenterUnknownAcute Hypoxemic Respiratory FailureKorea, Republic of
-
University Hospital, Clermont-FerrandCompletedPostoperative HypoxemiaFrance
-
Insel Gruppe AG, University Hospital BernThe Hospital for Sick Children; Children's Hospital of Philadelphia; Charite... and other collaboratorsRecruitingAirway ManagementSwitzerland, Canada, Germany
-
Shaare Zedek Medical CenterUnknown
-
University Hospital, Clermont-FerrandCompletedLaparoscopic Hysteretctomy With PromontofixationFrance
-
Institut für Pneumologie Hagen Ambrock eVCompleted
-
Guy's and St Thomas' NHS Foundation TrustCompletedChronic Obstructive Pulmonary Disease | Obesity Hypoventilation Syndrome | Neuromuscular Disease | Chronic Respiratory Hypercapnic FailureUnited Kingdom